An instrument to measure skeletal burden and predict functional outcome in fibrous dysplasia of bone

Journal of Bone and Mineral Research

Volumn 20, Issue 2, 2005, Pages 219-226

  Collins, Michael T ^a   Kushner, Harvey ^b   Reynolds, James C ^c   Chebli, Caroline ^d   Kelly, Marilyn H ^e   Gupta, Anurag ^a   Brillante, Beth ^e   Leet, Arabella I ^a,f   Riminucci, Mara ^g,h   Robey, Pamela Gehron ^a   Bianco, Paolo ^a,h,i   Wientroub, Shlomo ^j   Chen, Clara C ^c  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b Biomedical Computer Research Institute   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

^f JOHNS HOPKINS UNIVERSITY   (United States)

^g UNIVERSITY OF L'AQUILA   (Italy)

^h Biomedical Science Park San Raffaele   (Italy)

ⁱ SAPIENZA UNIVERSITY OF ROME   (Italy)

^j TEL AVIV UNIVERSITY   (Israel)

more..

Author keywords

Disease burden; Fibrous dysplasia; GNAS; Instrument; McCune Albright syndrome; Outcomes(s)

Indexed keywords

ALKALINE PHOSPHATASE; ALKALINE PHOSPHATASE BONE ISOENZYME; AMINO TERMINAL TELOPEPTIDE; BISPHOSPHONATE METHYLENE DIPHOSPHONATE; DEOXYPYRIDINOLINE; OSTEOCALCIN; PAMIDRONIC ACID; PYRIDINIUM DERIVATIVE; TECHNETIUM 99M; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGING; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BODY WEIGHT; BONE METABOLISM; BONE SCINTISCANNING; CHILD; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FIBROUS DYSPLASIA; HUMAN; INSTRUMENT; MAJOR CLINICAL STUDY; MALE; MOBILIZATION; QUALITY OF LIFE; SCORING SYSTEM; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; ALKALINE PHOSPHATASE; BIOLOGICAL MARKERS; BONE AND BONES; BONE DENSITY; CHILD; DIPHOSPHONATES; FEMALE; FIBROUS DYSPLASIA OF BONE; HUMANS; MALE; MIDDLE AGED; OBSERVER VARIATION; QUALITY OF LIFE; RADIONUCLIDE IMAGING; TREATMENT OUTCOME;

EID: 19944434190     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/JBMR.041111     Document Type: Article

References (24)

1. Bianco P, Riminucci M, Majolagbe A, Kuznetsov SA, Collins MT, Mankani MH, Corsi A, Bone HG, Wientroub S, Spiegel AM, Fisher LW, Robey PG 2000 Mutations of the GNAS1 gene, stromal cell dysfunction, and osteomalacic changes in non-McCune-Albright fibrous dysplasia of bone. J Bone Miner Res 15:120-128.
2. Bianco P, Robey PG, Wientroub S 2003 Fibrous dysplasia. In: Glorieux FH, Pettifor J, Juppner H (eds.) Pediatric Bone: Biology and Disease. Academic Press, Elsevier, New York, NY, USA, pp. 509-539.
3. Lichtenstein L, Jaffe HL 1942 Fibrous dysplasia of bone: A condition affecting one, several or many bones, graver cases of which may present abnormal pigmentation of skin, premature sexual development, hyperthyroidism or still other extraskeletal abnormalities. Arch Pathol 33:777-816.
4. Dorfman HD, Czerniak B 1998 Fibroosseous lesions. In: Dorfman HD, Czerniak B (eds.) Bone Tumors. Mosby, St Louis, MO, USA, pp. 441-491.
5. Weinstein LS, Shenker A, Gejman PV, Merino MJ, Friedman E, Spiegel AM 1991 Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med 325:1688-1695.
6. Shenker A, Chanson P, Weinstein LS, Chi P, Spiegel AM, Lomri A, Marie PJ 1995 Osteoblastic cells derived from isolated lesions of fibrous dysplasia contain activating somatic mutations of the Gs alpha gene. Hum Mol Genet 4:1675-1676.
7. Schwindinger WF, Francomano CA, Levine MA 1992 Identification of a mutation in the gene encoding the alpha subunit of the stimulatory G protein of adenylyl cyclase in McCune-Albright syndrome. Proc Natl Acad Sci USA 89:5152-5156.
8. Collins MT, Chebli C, Jones J, Kushner H, Consugar M, Rinaldo P, Wientroub S, Bianco P, Robey PG 2001 Renal phosphate wasting in fibrous dysplasia of bone is part of a generalized renal tubular dysfunction similar to that seen in tumor- induced osteomalacia. J Bone Miner Res 16:806-813.
9. Collins MT, Bianco P 2003 Fibrous dysplasia. In: Favus MJ (ed.) Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, 5th ed. American Society for Bone and Mineral Research, Washington, DC, USA, pp. 466-470.
10. McCune DJ 1936 Osteitis fibrosa cystica: The case of a nine-year-old girl who also exhibits precocious puberty, multiple pigmentation of the skin and hyperthyroidism. Am J Dis Child 52:743-744.
11. Albright F, Butler AM, Hampton AO, Smith P1937 Syndrome characterized by osteitis fibrosa disseminata, areas, of pigmentation, and endocrine dysfunction, with precocious puberty in females: Report of 5 cases. N Engl J Med 216:727-746.
12. Collins MT, Shenker A 1999 McCune-Albright syndrome: New insights. Curr Opin Endocrinol Diabetes 6:119-125.
13. Chapurlat RD, Meunier PJ 2000 Fibrous dysplasia of bone. Baillieres Best Pract Res Clin Rheumatol 14:385-398.
14. Feuillan PP, Jones J, Cutler GB Jr 1993 Long-term testolactone therapy for precocious puberty in girls with the McCune-Albright syndrome. J Clin Endocrinol Metab 77:647-651.
15. Gilday DL, Ash JM 1976 Benign bone tumors. Semin Nucl Med 6:33-46.
16. Imbriaco M, Larson SM, Yeung HW, Mawlawi OR, Erdi Y, Venkatraman ES, Scher HI 1998 A new parameter for measuring metastatic bone involvement by prostate cancer: The Bone Scan Index. Clin Cancer Res 4:1765-1772.
17. Pons F, Alvarez L, Peris P, Guanabens N, Vidal-Sicart S. Monegal A, Pavia J, Ballesta AM, Munos-Gomez J, Herranz R 1999 Quantitative evaluation of bone scintigraphy in the assessment of Paget's disease activity. Nucl Med Commun 20:525-528.
18. D'Addabbo A, Rubini G, Mele M, Lauriero F 1992 A new method for assessing 99Tcm-MDP bone uptake from a bone scan image: Quantitative measurement of radioactivity in global skeletal regions of interest. Nucl Med Commun 13:55-60.
19. Fogelman I, Bessent RG, Gordon D 1981 A critical assessment of bone scan quantitation (bone to soft tissue ratios) in the diagnosis of metabolic bone disease. Eur J Nucl Med 6:93-97.
20. ICRP 1975 Report of the Task Group on Reference Man, ICRP Publication 23. Pergammon Press, New York, NY, USA.
21. Ware JE, Kosinski M 2001 Interpreting SF-36 summary health measures: A response. Qual Life Res 10:405-420.
22. Landgraf JM, Abetz L, Ware JE 1999 The CHQ User's Manual. Health Act, Boston, MA, USA.
23. Leet AI, Chebli C, Kushner H, Chen CC, Kelly MH, Brillante BA, Robey PG, Bianco P, Wientroub S, Collins MT 2004 Fracture incidence in polyostotic fibrous dysplasia and the Mc-Cune-Albright syndrome. J Bone Miner Res 19:571-577.
24. Erdi YE, Humm JL, Imbriaco M, Yeung H, Larson SM 1997 Quantitative bone metastases analysis based on image segmentation. J Nucl Med 38:1401-1406.